离体
肺
灌注
体内
医学
冷库
肺移植
病理
内科学
生物
园艺
生物技术
作者
Ichiro Sakanoue,Toshihiro Okamoto,K.S. Ayyat,James Yun,Carol Farver,Hisashi Fujioka,Hiroshi Date,Kenneth R. McCurry
出处
期刊:Transplantation
[Ovid Technologies (Wolters Kluwer)]
日期:2023-09-20
被引量:2
标识
DOI:10.1097/tp.0000000000004802
摘要
Background. Ex vivo lung perfusion expands the lung transplant donor pool and extends preservation time beyond cold static preservation. We hypothesized that repeated regular ex vivo lung perfusion would better maintain lung grafts. Methods. Ten pig lungs were randomized into 2 groups. The control underwent 16 h of cold ischemic time and 2 h of cellular ex vivo lung perfusion. The intermittent ex vivo lung perfusion group underwent cold ischemic time for 4 h, ex vivo lung perfusion (first) for 2 h, cold ischemic time for 10 h, and 2 h of ex vivo lung perfusion (second). Lungs were assessed, and transplant suitability was determined after 2 h of ex vivo lung perfusion. Results. The second ex vivo lung perfusion was significantly associated with better oxygenation, limited extravascular water, higher adenosine triphosphate, reduced intraalveolar edema, and well-preserved mitochondria compared with the control, despite proinflammatory cytokine elevation. No significant difference was observed in the first and second perfusion regarding oxygenation and adenosine triphosphate, whereas the second was associated with lower dynamic compliance and higher extravascular lung water than the first. Transplant suitability was 100% for the first and 60% for the second ex vivo lung perfusion, and 0% for the control. Conclusions. The second ex vivo lung perfusion had a slight deterioration in graft function compared to the first. Intermittent ex vivo lung perfusion created a better condition for lung grafts than cold static preservation, despite cytokine elevation. These results suggested that intermittent ex vivo lung perfusion may help prolong lung preservation.
科研通智能强力驱动
Strongly Powered by AbleSci AI